Abstracts

942 – Immune Profile of Children With Post-COVID-19 Cardiac Contractility Alterations: A Prospective Study

Background Myocardial injuries have been observed after COVID-19 in previously healthy children, regardless of COVID-19 severity. Immune dysregulation may play a role in post-COVID cardiac alterations but remains unexplored in children. This study evaluated the immune response in children with or without asymptomatic cardiac contractility alterations after mild SARS-CoV-2 infection. Methods A prospective, observational study…

1023 – Cardiometabolic Outcomes in HEU vs HU Children in a SA Birth Cohort: Influence of Maternal Lipids

Background HIV-Exposed Uninfected (HEU) children have worse cardiometabolic health outcomes, compared to HIV-Unexposed uninfected (HU) children, but the effect of maternal cardiometabolic health in pregnancy on child outcomes is not clear. Our study investigated the impact of maternal gestational lipid biomarkers on child cardiometabolic health indicators in a birth cohort of South African HEU and…

1022 – Insulin-Like Growth Factors and Stunting in African Infants Exposed to HIV and Uninfected

Background The biological mechanisms related to increased risk of stunting in infants/children who are HIV-exposed and uninfected (CHEU) are not fully clear. We assessed whether insulin-like growth factors (IGFs), which are associated with infant growth, are determinants for stunting observed among CHEU. Methods A random sample of 213 out of 268 infants from the antepartum part of the IMPAACT P1084s…

1059 – Differentiated Service Delivery Programme Impact on Clinical Outcomes Among Adolescents With HIV

Background In sub-Saharan Africa, clinical outcomes among adolescents with HIV (AWH) on antiretroviral therapy (ART) remain sub-optimal. Differentiated service delivery (DSD) models for ART may facilitate better outcomes, but evidence on their effectiveness among AWH is lacking. We evaluated DSD uptake and outcomes among AWH living in KwaZulu-Natal (KZN), South Africa, following the introduction of…

1043 – Transcriptomics of Proviral Latency Reversal in Reservoirs of Youth With Perinatal HIV-1

Background Latency reversing agents (LRAs) such as TLR agonists and histone deacetylase (HDAC) inhibitors reactivate HIV-1 from latency in adults. We examined the immune effects of the TLR7 agonist GS-9620, alone and in combination with the HDAC inhibitor SAHA, in ex-vivo studies of adolescents with perinatal HIV-1 (AdLWPH), aiming to inform latency reversal strategies for…

1048 – Alternative Dosing of ABC/3TC Dispersible Tablets to Align With Dolutegravir Dosing in Neonates

Background Rapid maturation of metabolic/elimination pathways during the first month of life complicates using pediatric fixed-dose dispersible formulations in neonates. We previously reported that once daily administration of abacavir/lamivudine dispersible tablets (ABC/3TC-DT) to neonates gave high exposure during the first week of life. Administration of 5 mg dolutegravir (DTG) every 48 hours (q48) for the…

940 – Plasma Biomarkers in Children and Young People With Long COVID

Background Although most patients infected with SARS-CoV-2 recover, 10-20% can develop long-term persistent symptoms after the acute infection, a condition known as long COVID or Post-Acute Sequalae of SARS-CoV-2 (PASC). In this study we aim to compare autoantibodies, cytokines and  neuronal and vascular damage biomarkers in plasma from  children and young people (CYP) with and…